- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
John Castiglia, MD, Senior Vice President and Chief Medical Officer, Premera Blue Cross
A unique collaboration among Premera Blue Cross, its pharmacy benefits manager, Medco, and its DM provider, Healthways, drives the Faster ID initiative, which aims to identify potential DM-program participants quickly.
John Castiglia, MD
Senior Vice President, Chief Medical Officer
Premera Blue Cross
Seattle, Wash.
MHE research indicates it takes about 100 days to identify and contact members who would benefit from DM programs; however, Faster ID takes an average of 8 to 10 days.
Dr. Castiglia would like to see earlier identification of more members with other DM needs and believes that Faster ID is an important component of Premera's arsenal, along with wellness and care management, in improving care and member health. "The approach is a win-win situation for everyone," he says.
Prior to coming to Premera, Dr. Castiglia served as vice president of healthcare services for Regence Blue Shield, where he also served as vice president of medical management and as medical director. Previously, he was senior medical director for FHP. He earned a B.S. degree in zoology from Ohio State University, his medical degree from the Medical University of Ohio at Toledo and an MBA from Arizona State University.
Why Patient Registries Need to Make the Move From Tactical to Strategic Research Initiatives
September 6th 2022The one-sided, research-oriented approach has to change so patients have ready access to dashboards with their disease histories and pre-visit documents tailored to the patient questions.
Read More
Study: Patients with High Deductible Plans More Likely to Delay Care
September 7th 2021Patients faced with high out-of-pocket costs sometimes delay seeking care for appendicitis or diverticulitis, which can result in higher overall costs, increased risk of mortality, and a worse quality of life.
Read More
